Chemical genetic ATF6 activation reduces secretion and extracellular aggregation of ALLC without notably affecting secretion of a stable, non-amyloidogenic LC (Cooley et al., 2014). This evidence concerns the gene ATF6 and laryngotracheoesophageal cleft.